BACKGROUND: Premature prelabor rupture of fetal membranes accounts for 30% of all premature births and is associated with detrimental long-term infant outcomes. Premature cervical remodeling, facilitated by matrix metalloproteinases, may trigger rupture at the zone of the fetal membranes overlying the cervix. The similarities and differences underlying cervical remodeling in premature prelabor rupture of fetal membranes and spontaneous preterm labor with intact membranes are unexplored. OBJECTIVES: We aimed to perform the first transcriptomic assessment of the preterm human cervix to identify differences between premature prelabor rupture of fetal membranes and preterm labor with intact membranes and to compare the enzymatic activities of matrix metalloproteinases-2 and -9 between premature prelabor rupture of fetal membranes and preterm labor with intact membranes. STUDY DESIGN: Cervical biopsies were collected following preterm labor with intact membranes (n ¼ 6) and premature prelabor rupture of fetal membranes (n ¼ 5). Biopsies were also collected from reference groups at term labor (n ¼ 12) or term not labor (n ¼ 5). The Illumina HT-12 version 4.0 BeadChips microarray was utilized, and a novel network graph approach determined the specificity of changes between premature prelabor rupture of fetal membranes and preterm labor with intact membranes. Quantitative reverse transcriptionepolymerase chain reaction and Western blotting confirmed the microarray findings.
P reterm birth (PTB), defined as birth before 37 completed weeks of gestation, remains the major cause of neonatal morbidity and mortality affecting approximately 1 million pregnancies each year. 1 PTBs are predominantly spontaneous in nature and only 25% are iatrogenic. 2 Spontaneous PTBs (sPTBs) can be the outcome of spontaneous preterm labor with intact membranes (PTL; 45% of all sPTBs) or preterm prelabor rupture of membranes (PPROM; 30% of all sPTBs). 2 Although PTL is likely to follow PPROM, PTL and PPROM can present as separate entities because of differences in their initiating triggers and the underlying pathways leading to premature cervical remodeling. 3 The pathophysiology of PPROM has been poorly explored. It is believed that the tensile strength of the fetal membranes can be reduced by premature cervical dilation, which can expose the weakest zone of the fetal membranes to vaginal microorganisms and reduce the underlying tissue support. 4 Indeed, microbial invasion of the amniotic cavity is present in approximately 30e40% of patients with PPROM. 5 It is noteworthy that premature cervical remodeling in the absence of infection can also result in unscheduled rupture of fetal membranes. What triggers these cervical changes in the absence of infection and how these fine-tune the timing of rupture is currently unknown.
Genetic factors have been proposed to predispose women to PPROM, and a recent systematic review 6 reported that specific polymorphisms were associated with PPROM in blood, [7] [8] [9] amnion, 10, 11 and buccal swabs. 12, 13 From these a main regulation axis for PPROM was proposed, consisting of pathways regulating hematologic/coagulation function disorder, local inflammation, collagen metabolism, and matrix degradation. Notably, pregnant women with Ehlers-Danlos syndrome, an inherited connective tissue disorder resulting from mutations in genes responsible for collagen structure and/ or synthesis, have increased the risk for PPROM. 14, 15 A proteomic study of the human placenta additionally demonstrated an association of PPROM with alterations in structural/cytoskeletal components of cells and impaired regulation of energy metabolism and oxidative stress.
In light of the detrimental impact of PPROM on long-term infant outcomes, 17 the early and accurate prediction of the condition could allow for timely intervention to improve perinatal outcomes and reduce obstetric complications, such as chorioamnionitis, neonatal sepsis, or cord prolapse. Assessment of the cervical length and detection of biomarkers in biological fluids of symptomatic women serves to confirm suspected cases of PTL and microbial invasion of the amniotic cavity-associated PPROM, 18, 19 but a test that predicts PPROM before it occurs is yet to be developed.
Understanding the differences and similarities in the underlying pathologies associated with PPROM and PTL will allow new avenues for research and treatment. Herein we hypothesized that different cervical remodeling events facilitate PPROM and PTL. We set out to explore whether these different events would manifest as a PPROM-specific gene signature. To our knowledge this is the first genome-wide approach study utilizing human cervical biopsies to study PPROM and PTL as individual groups.
Materials and Methods

Human cervical biopsies
Cervical biopsies were collected at the Karolinska Hospital during 2006e2008 following the informed consent and approval of the local ethics committee. Biopsies were taken directly (within 30 minutes) after vaginal delivery or cesarean delivery (CD) transvaginally (at the 12 o'clock position) from the anterior cervical lip with scissors and tweezers. 20 A total of 28 women were recruited: 6 undergoing spontaneous PTL, 5 with PPROM followed by labor, 12 undergoing normal term labor (TL), and 5 who delivered at term prior to the onset of labor (TNL). Preterm delivery was defined as delivery before the 37th week of gestation.
Women in the PTL, PPPROM, and TL groups were in active labor and demonstrated a ripe cervix, with dilatation of more than 4 cm. All except 2 of these subjects delivered vaginally. One woman in the PTL group delivered by emergency CD because of breech presentation and one in the TL group because of protracted labor.
PPROM was defined as a rupture of membranes at least 1 hour before the onset of contractions.
2 TNL samples were obtained from women undergoing planned CD with an unripe cervix. None of the subjects had clinical signs of infection or chorioamnionitis or suffered from preeclampsia, diabetes, or other systemic disease. There were no significant differences between the groups of pregnant women with respect to maternal age, parity, or previous PTBs. For the clinical data of the recruited subjects, consult Supplemental Table 1 .
Sample processing
The samples were processed for RNA and protein extraction or fixed as detailed in Supplemental Material and Methods item 1.
Illumina HT-12 version 4.0 BeadChip expression microarray
A total of 23 samples were analyzed for quality control using the arrayQualityMetrics package in Bioconductor, 21 and no outliers were identified. The samples were split randomly over the Illumina HT-12 version 4.0 BeadChips (Illumina, Inc., San Diego, CA) to minimize any effect of interchip variability. The chips were imaged using a BeadArray Reader, and raw data were obtained with Illumina BeadStudio software. Raw and processed data are available (www.ebi.ac.uk/arrayexpress/ under accession number E-MTAB-5354). Sample-sample network graph of samples for microarray and comparisons Sample-sample network graph of all samples used for the microarray and the comparisons performed between the groups are shown. This is a 2-dimensional representation of sample clustering in a 3-dimensional graph. Each node represents a different sample, and edges are colored to reflect the Pearson correlation that they represent. Red and blue edges denote high correlation and low correlation, respectively. The same graph is colored by the following: A, no cluster (r ¼ 0.91); B, unbiased MCL cluster number (MCL, 19.3); C, group status; and D, table shows all the comparisons performed between groups and the number of significant array features at adjusted value of P < .01 and fold change !2. Numbers in each group are as follows: TL, n ¼ 7; TNL, n ¼ 5; PTL, n ¼ 6; and PPROM, n ¼ 5.
MCL, Markov cluster algorithm; PPROM, preterm premature rupture of membranes; PTL, preterm labor; TL, term labor; TNL, term nonlabor. 
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Microarray analysis
Fios Genomics Ltd (Bioquarter, Edinburgh, United Kingdom) performed the statistical analysis of the array as described in Supplemental Material and Methods item 2.
Network graph analysis
Normalized expression data generated by microarray analysis were further 
PPROM vs PTL comparison
A, Volcano plot. B, Heat map showing the 30 features significantly up-regulated (red dots) and 9 down-regulated (blue dots) at an adjusted value of P < .01 and fold change !2 in the PPROM group compared with the PTL group. A heat map shows how genes and samples cluster based on similar expression levels. The bars at the top indicate the sample group (dark green, TNL; dark blue, PTL; light green, TL; light blue, PPROM). Normalized expression values are indicated on a color scale, with red denoting high expression and blue low expression.
filtered to include only the up-or downregulated genes (P < .05, fold change ¼ any) in at least at 1 of 6 comparisons to eliminate the noise created by genes with conserved expression. That final data set was used as an input for Biolayout Express3D analysis software to create sample-sample and a gene-gene network graphs as previously described 22, 23 and further detailed in Supplemental Material and Methods item 3.
Quantitative RT-PCR
Quantitative reverse transcriptione polymerase chain reaction (qRT-PCR) (singleplex) was performed to validate the differences identified in the microarray and Biolayout Express3D analysis. The original samples used in the microarray were used for the validation, in addition to 5 new TL samples. Details about the assay are available in Supplemental Material and Methods item 4.
Western blotting and immunofluorescence
Western blotting and immunofluorescence were used to quantify and localize PML-RARA-regulated adapter molecule 1 (PRAM1), FYVE-RhoGEF and PH domain-containing protein 3 (FGD3), Carcinoembryonic antigen-ralated cell adhesion molecule 3 (CEACAM3) and N-myc downstream regulated gene 2 (NDRG2) proteins in the cervix as described in Supplemental Material and Methods item 5.
Gelatin zymography
A total of 20 mg of protein was loaded onto precast 10% Novex gelatincontaining gels (Thermo Scientific, Wilmington, DE) and separated by electrophoresis. Subsequently the gels were incubated with Novex renaturing and Novex developing buffer according to the manufacturers' protocol (Thermo Scientific). Staining was then performed using the Novex SimplyBlue SafeStain solution until the sites of membrane degradation by matrix metalloproteinase (MMP)-2 or MMP-9 manifested as bands on the zymographs. Zymography bands were quantified using Adobe Photoshop's CS6 histogram function. For zymography, the readout for statistical analysis was the raw pixel number for each band.
All data were initially analyzed for normal distribution using the Kolmogorov-Smirnov test. Western blotting (raw fluorescence ratio) and qRT-PCR (DDCt) data were analyzed with 1-way analysis of variance (ANOVA) Dunnett's test to compare each group with PPROM. Zymography data (raw pixel number) were analyzed with a 1-way ANOVA Tukey's test.
Significance was set at P <.05. Error bars denote the SEM.
Results
Microarray identified gene expression differences between PPROM and PTL
A sample-sample network graph followed by the Markov cluster algorithm (MCLi ¼ 19.3) analysis was generated from normalized microarray data ( Figure 1 , AeC) to understand the relationship between samples at a finer level. The proximity of the samples implied similarity in genetic signature ( Figure 1A ) and MCL analysis of the samples identified 4 clusters ( Figure B) .
When nodes were colored according to their group status ( Figure 1C ), it became evident that all 5 TNL samples belonged to the MCL cluster i, in which they shared cluster membership with 2 PTL samples. Additionally, MCL cluster ii contained 5 of 7 TL samples, which shared cluster membership with 4 PTL samples.
Three of 5 PPROM samples formed their own cluster (MCL cluster iii), and 1 PPROM sample clustered with 2 TL samples to form MCL cluster iv. One PPROM sample did not cluster with others, suggesting it did not genetically identify with other samples. Importantly, PPROM and PTL samples did not share cluster membership, and 60% of PPROM samples clustered together, suggesting a distinct genetic signature specific to the PPROM pathology. Indeed, a strict cutoff revealed that 44 genes were differentially expressed between the PPROM and PTL groups ( Figure 1D ), of which 32 were significantly up-regulated and 12 downregulated ( Figure 2A ).
A list of these genes is shown in Table 1 . A heat map analysis ( Figure 2B ) allowed for visual identification of the genes with a conserved PPROM-specific high or low expression across all PPROM samples when compared with all other samples (ie, FGD3, LILRA5, NDRG2, PRAM1, CD300LF, CEACAM3, PPDPF, RNA28S). Significantly changed genes in the PPROM-PTL comparison were analyzed for enrichment of Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway membership ( Table 2) and Gene Ontology (GO) terms (Table 3) . Osteoclast differentiation was the only overexpressed KEGG pathway in the PPROM group, when compared with PTL, with 5 significant genes up-regulated and 19 GO terms associated with immunity were enriched.
Pathological gene signature associated with PPROM
The normalized microarray data for the 30 up-and 9 down-regulated genes in the PPROM-PTL comparison were used as input to generate 2 gene-gene network graphs, in which each node represented a gene ( Figure 3 ). MCL analysis (MCLi ¼ 1.3) was performed to give an unbiased assessment of how the up-regulated ( Figure 3A ) and down-regulated genes ( Figure 3B ) clustered. GO term enrichment analysis of the up-and down-regulated genes that mapped to significant features at adjusted value of P < .001 ajog.org
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We identified 6 MCL clusters for the up-and 3 for the down-regulated genes ( Figure 3C ), and the average (mean) gene expression profile for each cluster was examined to detect a PPROM-specific signature (Figure 3 , DeL). As with the heat map, we identified the clusters with a high or low averaged expression of genes conserved across all PPROM samples. Analysis of MCL clusters 4 ( Figure 3G ) and 5 ( Figure 3H ) revealed that the averaged expression of genes in MCL cluster 4 (STK4, CEACAM3, FGD3) and MCL cluster 5 (PRAM1, MYO1F) was higher in the PPROM samples when compared with PTL, TL, and TNL samples.
MCL cluster interpretation relied on visual observation and no statistics were applied at that stage. From the downregulated MCL clusters, MCL 8 showed a low averaged expression for NDRG2 and ACOT13 in the PPROM samples 
, and 9 (L) across all samples (n ¼ 23), including the samples in the TL and TNL groups. Samples are plotted on the x-axes. Genes with similar expression pattern across all samples are members of the same cluster. Each bar represents the average expression of all genes that cluster together in that sample. The error bar for each sample denotes the SD extrapolated from the expression of all cluster genes in that sample. Numbers in each group are as follows: PPROM, n ¼ 5; PTL, n ¼ 6; TL, n ¼ 7; TNL, n ¼ 5.
MCL, Markov clustering algorithm; MCLi, Markov clustering algorithm with the inflation value; PPROM, preterm premature rupture of membranes; PTL, preterm labor; TL, term labor; TNL, term nonlabor. The concentration of FGD3 mRNA ( Figure 4H ) was also 3.34 AE 0.11-fold lower in PTL, 3.29 AE 0.08-fold lower in TL, and 2.7 AE 0,18-fold lower in TNL when compared with PPROM. In contrast, the mRNA of NDRG2 was in Validation of microarray analysis A, D, G, and J, Tables show the fold changes and adjusted P values across all comparisons for the 4 selected genes, CEACAM3, PRAM1, FGD3, and NDRG2, as reported by FIOS genomics statistical analysis. A qRT-PCR validated that CEACAM3 (B), PRAM1 (E), and FGD3 (H) were up-regulated and NDRG2 (K) down-regulated in the PPROM group when compared with all other groups. Data were analyzed using a 1-way ANOVA Dunnett's test. The qRT-PCR samples were as follows: PPROM, n ¼ 5; PTL, n ¼ 6; TL, n ¼ 12; TNL, n ¼ 5. Western blotting analysis confirmed that CEACAM3 (C) and FGD3 (I) were in higher concentration in the PPROM cervix compared with all other groups. PRAM1 (F) and NDRG2 (L) changes were also significant between PPROM and PTL/TL but not in TNL. Data were analyzed using a 1-way ANOVA Dunnett's test. Western blotting samples were as follows: PPROM, n ¼ 4; PTL, n ¼ 4; TL, n ¼ 4; TNL, n ¼ 4. Error bars denote AESEM. An asterisk indicates a value of P < .05. A double asterisk indicates a value of P < .01. A triple asterisk indicates a value of P < .001. These changes were confirmed in the protein level. CEACAM3 ( Figure 4C) and FGD3 ( Figure 4I ) were significantly higher in the PPROM group when compared with the other groups. CEA-CAM3 was 2.57 AE 0.06-fold lower in the PTL cervix, 2.65 AE 0.07-fold lower in the TL cervix, and 2.77 AE 0.07-fold lower in the TNL cervix. These values for FGD3 were 1.88 AE 0.09 for PTL, 2.02 AE 0.18 for TL, and 2.58 AE 0.24 for TNL. PRAM1 ( Figure 4F ) was significantly higher in PPROM compared with PTL (2.97 AE 0.15) and TL (3.5 AE 0.08) but not TNL. NDRG2 ( Figure 4L ) protein was significantly lower in the PPROM group when compared with PTL (e6.78 AE 0.5) and TL (7.0 AE 0.54) but not the TNL group.
PPROM-specific markers were localized to immune cells and vascular myofibroblasts
We explored the localization of PRAM1, CEACAM3, FGD3, and NDRG2 within the cervical tissue. Although the literature suggests that PRAM1 is predominantly expressed in granulocytes, it did not colocalize with the established granulocyte membrane marker CEA-CAM3 ( Figure 5D ). Instead, PRAM1 was localized to the cytoplasm of a subset of immune CD45-positive cells ( Figure 5H ) resident in the cervical stroma ( Figure 5 , C, F, I, and M). Notably, all PRAM1-positive cells stained for CD45, suggesting that these are immune cells. We confirmed that PRAM1-positive cells were neither macrophages ( Figure 5K ) nor neutrophils ( Figure 5O) .
Positive, albeit marginal, NDRG2 staining was evident in the nuclei of the endocervical epithelial cells (Figure 6C ), which were positive for pan-cytokeratin ( Figure 6B ). Strong NDRG2 staining ( Figure 6G ) was detected in the cytoplasm of endocervical glands ( Figure 6F ) and myofibroblasts surrounding blood vessels in the cervical stroma ( Figure 6D) .
A double staining with Von Willebrand factor (vWF), a marker expressed in the endothelial cells of the vasculature, confirmed the blood vessel status ( Figure 6J ). FDG3 was also expressed in the cytoplasm of myofibroblasts ( Figure 6P ) surrounding vWF-positive blood vessels ( Figure 6N ). We found that NDRG2 and FGD3 shared the same localization within myofibroblasts ( Figure 6T ).
GO terms for PRAM1, CEACAM3, FGD3, and NDRG2
All GO-enriched terms for the PPROMspecific markers can be found in Table 4 .
The activity of MMP-9 was higher in the PPROM cervix
Gelatin zymography revealed that the activity of MMP-9 ( Figure 7A ), but not MMP-2 ( Figure 7B ), was significantly higher in the PPROM cervix. Specifically, the activity of MMP-9 was higher 1.22 AE 4.403-fold in PPROM when compared with PTL (P < .05), 1.25 AE 4.328-fold compared with TL (P < .05), and 1.57 AE 6.600-fold compared with TNL (P < .001) ( Figure 7A ).
Comment
This is the first transcriptomic study of the preterm human cervix, which examined PTL and PPROM as 2 separate pathologies and compared gene expression in the 2 groups. According to a recent systematic review, only 4% of all transcriptomic studies in term and preterm human pregnancies have utilized cervical tissue, and, strikingly, none of these has examined PPROM individually. 24 Several genetic polymorphisms associated with PPROM have been identified in the placenta, membranes, and maternal/fetal blood (reviewed elsewhere 6 ), and smaller-scale studies also demonstrated the presence of PPROMassociated inflammatory markers in the amniotic fluid, 25, 26 fetal membranes, [27] [28] [29] and maternal serum. 30 All these studies combined with recent proteomic 16 and epigenetic 31 reports of a PPROM signature in the placenta and maternal blood have established the hypothesis that PPROM and PTL may have distinct underlying pathologies. It remained to be deduced whether a PPROM signature would be detected in the cervix. We hypothesized that the cervix might initiate rupture of the fetal membranes at their contact site through PPROM-specific cervical remodeling events. Our findings support this hypothesis and demonstrate that PPROM is associated with expression of key proteins, which may facilitate the organization of the cervical extracellular matrix (ECM) and indirectly accelerate membranes rupture.
The GO terms for the overexpressed genes in PPROM, when compared with PTL (Table 3) , were predominantly related to immunity (for example, immune system processes, immunity mediated by myeloid leukocytes, and immunity mediated by neutrophils). This is perhaps not surprising because physiological cervical remodeling is accompanied by infiltration of leukocyte subpopulations and neutrophils, which work to achieve the rigidity of the cervix. 32, 33 In line with our findings, a study in the mouse cervix proved that the overarching mechanism underlying cervical remodeling-associated immune cell influx is similar in term and preterm parturition, and only marginal differences occur whereby the mediators and effector cells involved may differ. 34 Our findings provide the first evidence to suggest that the immunity modulators used to mediate cervical remodeling may be additionally different between the preterm subgroups PPROM and PTL.
Immune modulators stimulate immune and other cells in the cervical stroma to produce cytokines and MMPs to degrade the ECM as part of the remodeling process. 4 ,35 MMP-2 and MMP-9 are gelatinases both capable of degrading collagens type I and III, the main constituents of the cervical ECM. 36 MMP-2 and MMP-9 concentration is reportedly elevated in the amniotic fluid of PPROM pregnancies. 25 Both MMP-2 and MMP-9 are produced by human cervical fibroblasts 20 and MMP-9 by vascular fibroblasts 37, 38 and neutrophil granulocytes. [39] [40] [41] To contribute to the notion that the facilitators of ECM degradation may differ between PPROM and PTL or TL in the cervix, we performed an assay to assess MMP-2 and MMP-9 activity. Indeed, the activity of MMP-9 was increased solely in PPROM.
Of the 44 differentially expressed genes between the PPROM and PTL groups identified with traditional array analysis, our network graph analysis followed by validation brought forward 4 key proteins that were over-or underexpressed only in the PPROM cervix. Although these proteins are novel to the parturition field, there is some evidence to support that they might be involved in the activation of a pathological cascade, which delivers a rupture signal to the weakest zone of fetal membranes overlying the cervix.
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OBSTETRICS Original Research Localization of FGD3 and NDRG2 in the human cervix Marginal NDRG2 staining (C) was detected on the nuclei of endocervical epithelial cells stained positive for AE1/AE3 (D). D, NDRG2 staining was evidently stronger in cells surrounding blood vessels (indicated with asterisks). A costaining for vWF (J; an endothelial cell marker) and NDRG2 (K) confirmed that NDRG2 is localized to the cytoplasm of myofibroblasts surrounding blood vessels (L). NDRG2 was also localized to the cytoplasm of endocervical glandular cells (G) as was evident by colocalization (H) with AE1/AE3 (F). Report of the GO terms containing the features PRAM1, FGD3, CEACAM3, and NDRG2 among other genes that mapped to significant features at adjusted value of P < .01 Report of the GO terms containing the features PRAM1, FGD3, CEACAM3, and NDRG2 among other genes that mapped to significant features at adjusted value of P < .01 (continued) ajog.org
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Specifically, NDRG2 may be switched off in cervical myofibroblasts to promote the production of MMP-9 and accelerate a PPROM-specific remodeling process. Down-regulation of NDRG2 has been previously associated with an increase in the gelatinolytic activities of MMP-2 and MMP-9 42 in adenocarcinomic human alveolar basal epithelial cell line, and more reports have shown direct inhibition of MMP-9 activity by NDRG2. [43] [44] [45] In support of this hypothesis, cathepsin D, which is also down-regulated in PPROM compared with PTL (Table 1) and shares GO terms with NDRG2 (Table 4) , is additionally a negative regulator of MMP-2 and MMP-9 in endometriotic lesions. 46 CEACAM3, a membrane granulocyte protein involved in neutrophil activation, 47, 48 and FGD3 may also work together toward enhancement of MMP-9 activity in PPROM.
It is not unlikely that aberrant infiltrating neutrophil-granulocytes overexpress CEACAM3 to promote their activation and stimulate MMP-9 secretion. In support of this notion, genes that share GO terms with CEACAM3 (Table 4) have also been associated with MMP actions. For example, the osteoclast-associated markers OSCAR and SIRPA and TREM-1 have all been implicated in MMP-9-mediated responses. [49] [50] [51] [52] CEACAM3 shares cluster membership with FGD3 ( Figure 3C ), suggesting similar regulation in gene expression, which itself may imply similar functions.
FGD3 may control MMP-9 activity in the PPROM cervix by promoting filopodia formation on the plasma membranes of myofibroblasts. 53 It is well established that proteins of the same family with FGD3 organize such formations on plasma membranes to release MMPs and in turn induce degradation of the surrounding stroma. 54, 55 Remarkably, blockade of filopodia formation by flavoinoids has been shown to decrease the release of MMP-2 in cancer. 56 Electron microscopy studies could help investigate filopodial formations on cells in PPROM.
PRAM1, which shared GO terms with FGD3 (Table  4) , is thought to be predominantly expressed in granulocyte-neutrophils in which it acts as an adaptor protein critical for select integrin functions. 57 Integrins are transmembrane receptors that bridge cell-ECM interactions and activate MMPs. 58 A proteolytic role for integrins has been described in the initiation of labor, whereby they regulate release of MMP-9 in human fetal membranes. 59 Although we did not detect PRAM1 in elastasepositive neutrophils or in CEACAM3-positive granulocytes ( Figure 5 ), the likehood of PRAM1 regulating integrin functions in the cytoplasm of an alternative immune cell population in the cervix deserves addressing. Using a genome-wide approach has identified key genes associated with PPROM and provided an insight into a potential mechanism regulating physiological cervical remodeling. Analysis of the 2 top clusters of the up-regulated genes in PPROM (Figure 3 , D and E) demonstrated that the genes within these clusters were overexpressed both in PPROM and, surprisingly, in TL. The first overexpressed cluster contained various genes involved in bone marrowederived cell migration (ARHGAP9, FGR, NFE2) and SLC43A2, the gene coding an essential transporter of branched chain amino acids (BCAAs). We propose a new mechanism to contribute to cervical remodeling in TL and PPROM, whereby the increase of BCAAs in the cervix triggers the recruitment of bone marrowederived cells to stimulate MMPinduced degradation.
Consistent with our hypothesis, MMP-2 and MMP-9 increase in response to exogenous BCAAs in the hippocampus of rats 60 and bone TABLE 4 Report of the GO terms containing the features PRAM1, FGD3, CEACAM3, and NDRG2 among other genes that mapped to significant features at adjusted value of P < .01 (continued) (Table 2 ) but also in TL-PTL (Supplemental Table 3 ).
Osteoclasts are bone marrowederived cells traditionally involved in the degradation of bone matrix 64 and have been described to secrete MMP-2 and MMP-9. 62, 63 Further work is required to prove whether bone marrowederived osteoclasts or osteoclast-like cells mediate MMPs-induced degradation of ECM as part of a physiological cervical remodeling cascade.
It is noteworthy that only 16 genes were differentially expressed between PPROM and TL, in contrast to 1285 genes in the TNL-TL comparison. The notion that PPROM and TL might share some similar pathways for cervical remodeling was additionally supported by the sample-sample network graph ( Figure 1C ). In that graph PPROM and TL samples belonged to the same loose local structure, whereas the TNL samples belong to a separate tight structure.
Our study could benefit from a larger sample size, but human cervical biopsies are extremely hard to obtain, especially in relation to preterm delivery, which explains why so few studies are conducted on the human preterm cervix. Moreover, the biopsies were collected postpartum, and thus, a postpartum repair mechanism might be reflected in our results. However, it is not practically and ethically possible to obtain cervical biopsies during a vaginal delivery, and the material used in our study was collected within 30 minutes after delivery. Animal research, for example, clustered regularly interspaced short palindromic repeats experiments, could be useful in future studies to identify the phenotype associated with knockout or knock-in of the genes we suggest are important.
In summary, we have, for the first time, identified a gene expression signature involved with PPROM. It is tempting to hypothesize that the PPROM-specific proteins identified herein act as contributors in a pathway whereby MMP-9 facilitates ECM degradation in the cervix to signal a rupture message to the overlying membranes. Our work supports the growing body of evidence suggesting that premature labor is a multifactorial disorder with different pathways involved for PPROM and PTL.
n Supplemental Material and Methods
Sample processing
The clinical data for the samples is shown in Supplemental Table 1 . For mRNA analysis, the collected samples were immediately immersed in RNAlater (Ambion Inc, Austin, TX), kept at 4 o C for 24 hours, and thereafter frozen and stored at e80 o C. For protein analysis, the samples were directly frozen and stored at e80 o C. The biopsies for immunohistochemistry were rinsed in physiological saline solution and fixed in 4% formaldehyde for 24 hours and thereafter dehydrated in 70% ethanol and embedded in paraffin. For RNA extraction, the tissue was thawed and homogenized in TRI Reagent reagent (Qiagen, Valencia, CA). For protein extraction the tissue was homogenized in RIPA buffer (Sigma Aldricht, Irvine, United Kingdom) supplemented with cOmplete protease inhibitor cocktail (Sigma Aldrich) using TissueLyser II (Qiagen). Total RNA was extracted using the RNeasy minikit (Qiagen) according to the manufacturer's instructions. The quantity and quality of RNA was assessed using a NanoDrop 1000 (Thermo Scientific, Wilmington, DE). For qRT-PCR, cDNA was synthesized from 30 ng/mL RNA using the high-capacity cDNA reverse transcription kit (Thermo Scientific). To prepare the samples for the microarray experiment, 500 ng of total RNA was amplified and biotin labeled using the Illumina TotalPrepTM RNA amplification kit (Ambion). The RNA quality of the biotin-labeled samples was assessed using a Bioanalyzer 2100 (Agilent Technologies, Wilmington, DE).
Microarray analysis
The factors in the experimental design were assessed for confounding factors. The assessment was performed using pair-wise univariate associations between all combinations of factors. The statistical tests utilized depended on the property of the factors: for an association between 2 categorical factors, a c 2 test was used. For an association between a categorical and a continuous factor, an ANOVA was used. For an association between 2 continuous factors, a Spearman correlation test was used. In all cases, the resulting P value was transformed as elog10(p) before being visualized in the confounding factors heatmap. Raw data were transformed using a variance stabilizing transformation method prior to normalization across all arrays using the robust spline normalization method. A series of 6 group-wise comparisons was undertaken to identify differences (fold changes). Each fold change has associated significance statistics, but because the number of significance tests being done is equal to the number of features, the significance values were controlled for false discovery, yielding a more rigorous adjusted P value. For the current data set, the adjusted value of P < .01 and fold chance (fc) !2 were appropriate for the comparisons performed. Having chosen a threshold for significance (adjusted value, P < .01), significant features in each comparison were assessed for functional enrichment of KEGG pathways and GO terms, based on their annotation information using a hypergeometric test. The level of statistical significance for functional analysis was chosen to be the most stringent level at which 1% of the features were, on average, significant. Enrichment (P <.05) was assessed for upand down-regulated genes separately.
Network graph analysis
In the sample-sample graph, each node (sphere) represented a sample connected to others by edges weighted according to the strength of the sample-sample Pearson's correlation coefficient. All correlation values (r) greater than 0.91 were used to draw a graph of this similarity matrix. Samples appear closer to each other and create a local structure in the graph if they share similarities in gene expression. This tactic was used to examine whether samples belonging to the same group would appear close to each other within the matrix, suggesting similarity in their genetic signatures. The MCL 23 was performed with the inflation value (MCLi) set at 19.3 to give an unbiased assessment of how the samples clustered. In the genegene graph, each node represented a gene. Genes that appeared closer in the graph shared similar expression profile across all samples, which is the degree of coregulation in all samples. Pearson's correlation coefficient threshold, r ¼ 0.80, was used to build the 3-dimensional graph. MCL clustering (MCLi ¼ 1.3) was performed to give an unbiased assessment of how the genes cluster. Average (mean) expression profiles for each cluster were examined using the Pareto-scale analysis of BLE in which error bars denote SD.
Quantitative RT-PCR
Gene expression was determined using the DDCt method, relative to the housekeeping gene ACTB. Predesigned, inventoried TaqMan gene expression assays (Thermo Scientific) were used to measure the expression of genes: PRAM1 (Hs00738098_ m1), FGD3 (Hs00382004_m1), CEACAM3 (Hs00926319_g1), NDRG2 (Hs01045114_g1), and ACTB (4310881E). The qRT-PCR was performed on the ABI 7900HT (Applied Biosystems, Carlsbad, CA), using 384-well plates.
Western blotting and immunofluorescence
Total extracted protein was separated on NuPAGE 4-12% Bis-Tris precast gels (Thermo Scientific) and transferred to Immobilon-FL polyvinylidene difluoride membranes (Millipore, Hertfordshire, United Kingdom). Membranes were blocked in 5% Marvel/0.2% Tween-20 (Sigma Aldrich) for 1 hour at room temperature and probed overnight at 4 C with 2 antibodies (a loading control [atubulin] and an antibody] to detect the proteins of interest: PRAM1, CEACAM3, FGD3, and NDRG2. Bands were visualized and analyzed on LI-COR Odyssey scanner (LI-COR Biosciences, Lincoln, NE) following 1 hour of exposure to secondary antibodies IRDye 800CW and with IRDye 680RD (LI-COR Biosciences). Consult Supplemental Table 2 for antibody details. For localization studies, the expression of the proteins of interest in the cervix was examined by immunofluorescence. Slides were dewaxed, rehydrated, antigen retrieved at 0.01 M citrate buffer (pH 6.0, where required), incubated in 3% (volume/volume) H 2 Original Research OBSTETRICS ajog.org
